Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Revive Therapeutics Ltd C.RVV

Alternate Symbol(s):  RVVTF

Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics and diagnostics for infectious diseases, medical countermeasures, and rare disorders. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. It also advancing the development of Psilocybin-based therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).


CSE:RVV - Post by User

Comment by Trippedstockson Feb 13, 2021 6:39pm
107 Views
Post# 32563104

RE:RE:RE:RE:UCSF - Medical Center

RE:RE:RE:RE:UCSF - Medical Center
it will meet it's enrollment number goals. Again what do they mean by pace? They have not meet estimated trial timelines.

they said in October "it is estimated that over 200 patients will have completed the Study for the interim analysis by the end of December 2020." And we know the trial started late, Nov27. They were wrong on their estimate then.

did they add more sites because they didn't have a quick enough enrollment for the 210. The 210 is part of the overall 1000
<< Previous
Bullboard Posts
Next >>